Search & Analyze

Molbio Diagnostics Ltd.

1,274.65−28.90 (−2.22%)

BSE · 30 Oct, 4:01 PM

: ₹14,689.07 Cr
: 88.17
: 88,985
: ₹1,344.00 - ₹1,266.90
: ₹1,686.50 - ₹925.80

Molbio Diagnostics Ltd. (MOLBIO) share price closed at ₹1,274.65 on the BSE on Friday, October 30, 2026, down by 2.22% from its of ₹1,303.55. In that session MOLBIO reached a of 1,344.00 and of 1,266.90. The for the session was 1,306.44. The stands at 1,289.54. Looking at , the stock ended the session in Downtrend.

Stock Overview

₹1,313.50

₹1,303.55

₹1,306.44

₹1,289.54

Price 1.15% below

Key Fundamentals

: 14,689.07 Cr₹14.69 Thousand Crore
: 14.46
: 88.17
: 10.33
: 123.42
: 330.93 Cr₹330.93 Crore
: 0.00 %
Sector
Industry: Medical Equipment/Supplies/Accessories
: 15.36
: 0.35

Industry Comparison

Ratio	Company	Sector
	88.17	44.77
	0.35	0.20
	10.33	4.61
	2.48	1.81
	0.00 %	0.11 %
Operating Margin	22.23 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
LENSKART LENSKART	678.20	179.99	1,17,959.74	0.00	228.43	273.43%	2,714.18	43.27%	12.55
Molbio Diagnostics Ltd. MOLBIO	1,274.65	88.17	14,689.07	0.00	52.74	320.28%	408.38	309.57%	19.79
POLY MEDICUR POLYMED	1,447.80	46.58	14,675.11	0.24	85.27	-8.39%	525.38	30.30%	14.05
SMT SMT	459.95	71.61	4,675.24	0.00					11.93
3BBLACKBIO 3BBLACKBIO	1,298.95	20.04	1,114.85	0.39	8.98	-28.99%	33.49	50.62%	25.90
LAXMIDENTL LAXMIDENTL	177.80	31.67	978.42	0.00	10.32	23.83%	74.70	13.87%	13.29
GKB OPHTHA GKB	59.00	9.06	29.74	0.00	1.85	387.99%	33.04	2.28%	8.82

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2025	Jun 2026
	99.71	408.38
Expenses	114.96	307.79
	-15.26	100.58
	-15.30%	24.63%
	0.76	3.10
Interest	3.61	10.70
	12.32	17.08
	-31.28	75.91
	23.45%	30.52%
	-23.71	58.75
	-10.51	5.21

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
INCOME :
	332.46	836.56	1,020.42	1,445.69
	332.46	836.56	1,020.42	1,445.69
EXPENDITURE :
Increase/Decrease in Stock	-43.03	19.68	-22.47	1.29
Raw Material Consumed	186.30	320.75	437.31	574.89
Power & Fuel Cost	6.47	7.44	10.01	11.60
Employee Cost	49.73	63.89	102.79	145.23
Other Manufacturing Expenses	15.42	27.06	43.66	56.24
General and Administration Expenses	30.26	42.23	52.77	79.65
Selling and Distribution Expenses	28.76	67.01	97.79	208.02
Miscellaneous Expenses	15.39	54.33	36.33	47.35
	289.30	602.38	758.20	1,124.24
Operating Profit (Excl OI)	43.16	234.18	262.22	321.44
	4.95	4.10	7.52	9.48
	48.11	238.28	269.74	330.93
Interest	6.85	14.45	17.66	33.47
PBDT	41.26	223.83	252.08	297.46
	31.72	41.01	44.55	63.64
Profit Before Taxation & Exceptional Items	9.54	182.83	207.53	233.82
Exceptional Income / Expenses		-53.17	-11.13	-0.49
	9.54	129.64	194.43	231.14
Provision for Tax	12.99	46.10	55.85	67.00
	-3.45	83.54	138.58	164.14
Extra items	0.00	0.00	0.00	0.00
Minority Interest	2.72	18.41	6.52	2.45
Consolidated Net Profit	-0.73	101.95	145.10	166.59
Profit Balance B/F	518.95	518.39	620.29	764.65
Appropriations	518.23	620.34	765.40	931.25
	-3.22	452.32	64.32	14.77
Adjusted EPS	-0.06	9.05	12.86	14.77

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	2.25	2.25	2.26	11.28
Share Warrants & Outstandings	0.35	0.35
Total Reserves	718.88	820.78	966.14	1,158.06
Reserve excluding Revaluation Reserve	718.88	820.78	966.14	1,158.06
Revaluation reserve	0.00	0.00	0.00	0.00
	721.48	823.38	968.39	1,169.34
Minority Interest	15.86	5.46	-1.11	139.44
Secured Loans	0.99	15.12	6.14	212.41
Deferred Tax Assets / Liabilities	-5.18	-26.01	-46.65	-18.44
Other Long Term Liabilities	31.55	29.33	42.11	27.20
Long Term Provisions	1.53	1.90	4.05	9.57
Total Non-Current Liabilities	28.88	20.34	5.66	230.74
Trade Payables	85.52	93.99	230.21	199.50
Other Current Liabilities	53.89	78.14	84.11	144.37
Short Term Borrowings	105.74	149.00	105.75	180.23
Short Term Provisions	12.40	21.64	21.59	33.26
Total Current Liabilities	257.55	342.76	441.66	557.36
Total Liabilities	1,023.77	1,191.94	1,414.61	2,096.87
Gross Block	388.57	414.61	484.61	787.33
Less: Accumulated Depreciation	102.36	158.22	195.10	250.96
	286.21	256.39	289.51	536.37
		1.58	27.33	11.32
Non Current Investments	6.01	5.99	45.57	5.98
Long Term Investment	6.01	5.99	45.57	5.98
Long Term Loans & Advances	78.78	48.57	93.83	81.94
Other Non Current Assets	30.68	23.29	28.54	76.42
Total Non-Current Assets	407.03	368.78	484.78	712.03
Inventories	347.02	315.14	435.91	449.26
Sundry Debtors	188.76	425.45	271.66	408.74
Cash and Bank	7.24	22.11	129.05	367.11
Other Current Assets	11.73	8.75	6.70	19.67
Short Term Loans and Advances	56.69	51.71	86.50	140.07
Total Current Assets	611.42	823.16	929.83	1,384.84
Net Current Assets (Including Current Investments)	353.88	480.40	488.17	827.48
Total Assets	1,023.77	1,191.94	1,414.61	2,096.87
	58.69	76.06	110.61	168.74
Total Debt	108.44	174.58	123.16	412.64
	3,199.33	3,651.42	429.25	103.70
Adjusted Book Value	63.99	73.03	85.85	103.70

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00
	9.54	129.64	194.43	231.14
Adjustment	37.52	143.49	90.68	121.69
Changes In working Capital	55.22	-220.10	81.86	-231.76
Cash Flow after changes in Working Capital	102.28	53.04	366.97	121.07
Cash Flow from Operating Activities	64.13	9.57	287.10	50.39
Cash Flow from Investing Activities	-39.73	-45.01	-122.65	-93.22
Cash Flow from Financing Activitie	18.24	-31.55	-26.15	276.07
Net Cash Inflow / Outflow	42.64	-66.99	138.30	233.23
Opening Cash & Cash Equivalents	-50.72	-8.08	-75.07	63.23
Cash & Cash Equivalent on Amalgamation / Take over / Merger				24.49
Effect of Foreign Exchange Fluctuations				14.82
Closing Cash & Cash Equivalent	-8.08	-75.07	63.23	335.77

Ratios

Valuation

88.17

10.33

44.53

10.16

14.46

123.42

Profitability

15.36

19.79

9.35

22.23

11.35

Leverage & Liquidity

0.35

2.48

7.91

Returns

0.00

0.82

Shareholding Pattern

Numbers in percentages

Particulars	Aug '26	Sep '26
	41.29	41.29
	17.88	20.67
	40.82	38.03
	58.71	58.71
No. of Shareholders	2,33,544	50,395

Mutual Funds Invested(32)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 32 active funds hold 10.03% in Molbio Diagnostics Ltd., contributing to ₹1.51K Cr of holdings

Fund				As of
KO Kotak Mid Cap Fund - Growth - Direct PlanMid Cap Fund	359.95	0.54	27,50,000	Sep '26
HD HDFC Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	301.05	0.28	23,00,000	Sep '26
KO Kotak Aggressive Hybrid Fund - Growth - Direct PlanHybrid - Aggressive Hybrid Fund	196.34	2.17	15,00,000	Sep '26
HD HDFC Pharma and Healthcare Fund - Growth - Direct PlanPharma & Health Care	70.42	2.01	5,38,006	Sep '26
KO Kotak Contra Fund - Growth - Direct PlanEquity - Contra Fund	68.01	1.31	5,19,576	Sep '26
MI Mirae Asset Healthcare Fund - Growth - Direct PlanPharma & Health Care	61.89	1.77	4,72,842	Sep '26
NI Nippon India Pharma Fund - Growth - Direct PlanPharma & Health Care	49.78	0.54	3,80,293	Sep '26
MI Mirae Asset Flexi Cap Fund - Growth - Direct PlanFlexi Cap Fund	45.81	1.05	3,50,000	Sep '26
KO Kotak Large Cap Fund - Growth - Direct PlanLarge Cap Fund	45.11	0.43	3,44,626	Sep '26
HD HDFC Value Fund - Growth - Direct PlanEquity - Value Fund	43.67	0.54	3,33,622	Sep '26

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-09-01	Board Meeting	Quarterly Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcareMedical Equipment/Supplies/Accessories

Molbio Diagnostics Ltd. operates in the Healthcare sector under the Medical Equipment/Supplies/Accessories industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

7 members across the board and senior leadership

Sriram Natarajan

Executive Director & Chief Executive Officer

₹2.44 Cr

Mar '26

Chandrasekhar Bhaskaran Nair

Executive Director & Chief Technology Officer

—

Sangeetha Sriram

Executive Director - Operations

₹1.44 Cr

Mar '26

Arun Kumar Jha

Non Executive Independent Director

₹15.00 L

Mar '26

Balram Bhargava

Non Executive Independent Director

₹15.00 L

Mar '26

Nupur Garg

Non Executive Independent Director

₹15.00 L

Mar '26

Darshan Karekar

Company Secretary & Compliance Officer

—

MOLBIO Latest News

News

6 of 6 articles

EQUITY16 Oct 2026 · 11:55

Molbio Diagnostics informs about disclosure

EQUITY13 Oct 2026 · 11:34

Molbio Diagnostics informs about disclosure

EQUITY24 Sept 2026 · 17:26

Molbio Diagnostics informs about SAST

EQUITY7 Sept 2026 · 11:26

Molbio Diagnostics informs about press release

EQUITY17 Aug 2026 · 10:47

Molbio Diagnostics lists with 21% premium on the BSE

The scrip is currently trading at Rs. 1018.00, up by 211.00 points or 26.15% from its issue price

IPO7 Aug 2026 · 16:12

Molbio Diagnostics coming with IPO to raise up to Rs 950.03 crore

The issue will open for subscription on August 10, 2026 and will close on August 12, 2026

Molbio Diagnostics Ltd.

Stock Overview

Price chart

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Valuation

Profitability

Leverage & Liquidity

Returns

Shareholding Pattern

Mutual Funds Invested(32)

Corporate Actions

Insider Trading

Sector Overview

Company Profile

Key Management

MOLBIO Latest News

News